| Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|
| Buys | ||||
| Sells | -60,161 | 100% | $268.44 | -$16,149,383 |
| Net | -60,161 | -100% | -$16,149,383 |
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 85,096 | $23,513,318 | $276.32 | 26 Feb 2026 | Directly beneficially owned by Alta Bioequities, L.P. | ||
| Common Stock | 0 | $0 | $271.09 | 24 Feb 2026 | Direct | ||
| Stock Option (Right to Buy) | 0 | 24 Feb 2026 | Direct | Common Stock |
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|